Acute	0	5	O
ethanol	6	13	B-Drug_or_compound
exposure	14	22	O
disrupts	23	31	O
VEGF	32	36	B-Gene_or_gene_product
receptor	37	45	I-Gene_or_gene_product
cell	46	50	O
signaling	51	60	O
in	61	63	O
endothelial	64	75	B-Cell
cells	76	81	I-Cell
.	81	82	O

Physiological	84	97	O
angiogenesis	98	110	O
is	111	113	O
regulated	114	123	O
by	124	126	O
various	127	134	O
factors	135	142	O
,	142	143	O
including	144	153	O
signaling	154	163	O
through	164	171	O
vascular	172	180	B-Gene_or_gene_product
endothelial	181	192	I-Gene_or_gene_product
growth	193	199	I-Gene_or_gene_product
factor	200	206	I-Gene_or_gene_product
(	207	208	I-Gene_or_gene_product
VEGF	208	212	I-Gene_or_gene_product
)	212	213	I-Gene_or_gene_product
receptors	214	223	I-Gene_or_gene_product
.	223	224	O

We	225	227	O
previously	228	238	O
reported	239	247	O
that	248	252	O
a	253	254	O
single	255	261	O
dose	262	266	O
of	267	269	O
ethanol	270	277	B-Drug_or_compound
(	278	279	O
1	279	280	O
.	280	281	O
4	281	282	O
g	283	284	O
/	284	285	O
kg	285	287	O
)	287	288	O
,	288	289	O
yielding	290	298	O
a	299	300	O
blood	301	306	B-Organism_substance
alcohol	307	314	B-Drug_or_compound
concentration	315	328	O
of	329	331	O
100	332	335	O
mg	336	338	O
/	338	339	O
dl	339	341	O
,	341	342	O
significantly	343	356	O
impairs	357	364	O
angiogenesis	365	377	O
in	378	380	O
murine	381	387	B-Organism
wounds	388	394	B-Pathological_formation
,	394	395	O
despite	396	403	O
adequate	404	412	O
levels	413	419	O
of	420	422	O
VEGF	423	427	B-Gene_or_gene_product
,	427	428	O
suggesting	429	439	O
direct	440	446	O
effects	447	454	O
of	455	457	O
ethanol	458	465	B-Drug_or_compound
on	466	468	O
endothelial	469	480	B-Cell
cell	481	485	I-Cell
signaling	486	495	O
(	496	497	O
40	497	499	O
)	499	500	O
.	500	501	O

To	502	504	O
examine	505	512	O
the	513	516	O
mechanism	517	526	O
by	527	529	O
which	530	535	O
ethanol	536	543	B-Drug_or_compound
influences	544	554	O
angiogenesis	555	567	O
in	568	570	O
wounds	571	577	B-Pathological_formation
,	577	578	O
we	579	581	O
employed	582	590	O
two	591	594	O
different	595	604	O
in	605	607	O
vitro	608	613	O
angiogenesis	614	626	O
assays	627	633	O
to	634	636	O
determine	637	646	O
whether	647	654	O
acute	655	660	O
ethanol	661	668	B-Drug_or_compound
exposure	669	677	O
(	678	679	O
100	679	682	O
mg	683	685	O
/	685	686	O
dl	686	688	O
)	688	689	O
would	690	695	O
have	696	700	O
long	701	705	O
-	705	706	O
lasting	706	713	O
effects	714	721	O
on	722	724	O
VEGF	725	729	B-Gene_or_gene_product
-	729	730	O
induced	730	737	O
capillary	738	747	B-Multi-tissue_structure
network	748	755	I-Multi-tissue_structure
formation	756	765	O
.	765	766	O

Ethanol	767	774	B-Drug_or_compound
exposure	775	783	O
resulted	784	792	O
in	793	795	O
reduced	796	803	O
VEGF	804	808	B-Gene_or_gene_product
-	808	809	O
induced	809	816	O
cord	817	821	B-Tissue
formation	822	831	O
on	832	834	O
collagen	835	843	B-Gene_or_gene_product
and	844	847	O
reduced	848	855	O
capillary	856	865	B-Multi-tissue_structure
network	866	873	I-Multi-tissue_structure
structure	874	883	O
on	884	886	O
Matrigel	887	895	O
in	896	898	O
vitro	899	904	O
.	904	905	O

In	906	908	O
addition	909	917	O
,	917	918	O
ethanol	919	926	B-Drug_or_compound
exposure	927	935	O
decreased	936	945	O
expression	946	956	O
of	957	959	O
endothelial	960	971	O
VEGF	972	976	B-Gene_or_gene_product
receptor	977	985	I-Gene_or_gene_product
-	985	986	I-Gene_or_gene_product
2	986	987	I-Gene_or_gene_product
,	987	988	O
as	989	991	O
well	992	996	O
as	997	999	O
VEGF	1000	1004	B-Gene_or_gene_product
receptor	1005	1013	I-Gene_or_gene_product
-	1013	1014	I-Gene_or_gene_product
2	1014	1015	I-Gene_or_gene_product
phosphorylation	1016	1031	O
in	1032	1034	O
vitro	1035	1040	O
.	1040	1041	O

Inhibition	1042	1052	O
of	1053	1055	O
ethanol	1056	1063	B-Drug_or_compound
metabolism	1064	1074	O
by	1075	1077	O
4	1078	1079	B-Drug_or_compound
-	1079	1080	I-Drug_or_compound
methylpyrazole	1080	1094	I-Drug_or_compound
partially	1095	1104	O
abrogated	1105	1114	O
the	1115	1118	O
effect	1119	1125	O
of	1126	1128	O
ethanol	1129	1136	B-Drug_or_compound
on	1137	1139	O
endothelial	1140	1151	B-Tissue
cell	1152	1156	I-Tissue
cord	1157	1161	I-Tissue
formation	1162	1171	O
.	1171	1172	O

However	1173	1180	O
,	1180	1181	O
mice	1182	1186	B-Organism
treated	1187	1194	O
with	1195	1199	O
t	1200	1201	B-Drug_or_compound
-	1201	1202	I-Drug_or_compound
butanol	1202	1209	I-Drug_or_compound
,	1209	1210	O
an	1211	1213	O
alcohol	1214	1221	B-Drug_or_compound
not	1222	1225	O
metabolized	1226	1237	O
by	1238	1240	O
alcohol	1241	1248	B-Gene_or_gene_product
dehydrogenase	1249	1262	I-Gene_or_gene_product
,	1262	1263	O
exhibited	1264	1273	O
no	1274	1276	O
change	1277	1283	O
in	1284	1286	O
wound	1287	1292	O
vascularity	1293	1304	O
.	1304	1305	O

These	1306	1311	O
results	1312	1319	O
suggest	1320	1327	O
that	1328	1332	O
products	1333	1341	O
of	1342	1344	O
ethanol	1345	1352	B-Drug_or_compound
metabolism	1353	1363	O
are	1364	1367	O
important	1368	1377	O
factors	1378	1385	O
in	1386	1388	O
the	1389	1392	O
development	1393	1404	O
of	1405	1407	O
ethanol	1408	1415	B-Drug_or_compound
-	1415	1416	O
induced	1416	1423	O
changes	1424	1431	O
in	1432	1434	O
endothelial	1435	1446	B-Cell
cell	1447	1451	I-Cell
responsiveness	1452	1466	O
to	1467	1469	O
VEGF	1470	1474	B-Gene_or_gene_product
.	1474	1475	O

In	1476	1478	O
vivo	1479	1483	O
,	1483	1484	O
ethanol	1485	1492	B-Drug_or_compound
exposure	1493	1501	O
caused	1502	1508	O
both	1509	1513	O
decreased	1514	1523	O
angiogenesis	1524	1536	O
and	1537	1540	O
increased	1541	1550	O
hypoxia	1551	1558	O
in	1559	1561	O
wounds	1562	1568	B-Pathological_formation
.	1568	1569	O

Moreover	1570	1578	O
,	1578	1579	O
in	1580	1582	O
vitro	1583	1588	O
experiments	1589	1600	O
demonstrated	1601	1613	O
a	1614	1615	O
direct	1616	1622	O
effect	1623	1629	O
of	1630	1632	O
ethanol	1633	1640	B-Drug_or_compound
on	1641	1643	O
the	1644	1647	O
response	1648	1656	O
to	1657	1659	O
hypoxia	1660	1667	O
in	1668	1670	O
endothelial	1671	1682	B-Cell
cells	1683	1688	I-Cell
,	1688	1689	O
as	1690	1692	O
ethanol	1693	1700	B-Drug_or_compound
diminished	1701	1711	O
nuclear	1712	1719	O
hypoxia	1720	1727	B-Gene_or_gene_product
-	1727	1728	I-Gene_or_gene_product
inducible	1728	1737	I-Gene_or_gene_product
factor	1738	1744	I-Gene_or_gene_product
-	1744	1745	I-Gene_or_gene_product
1alpha	1745	1751	I-Gene_or_gene_product
protein	1752	1759	O
levels	1760	1766	O
.	1766	1767	O

Together	1768	1776	O
,	1776	1777	O
the	1778	1781	O
data	1782	1786	O
establish	1787	1796	O
that	1797	1801	O
acute	1802	1807	O
ethanol	1808	1815	B-Drug_or_compound
exposure	1816	1824	O
significantly	1825	1838	O
impairs	1839	1846	O
angiogenesis	1847	1859	O
and	1860	1863	O
suggest	1864	1871	O
that	1872	1876	O
this	1877	1881	O
effect	1882	1888	O
is	1889	1891	O
mediated	1892	1900	O
by	1901	1903	O
changes	1904	1911	O
in	1912	1914	O
endothelial	1915	1926	B-Cell
cell	1927	1931	I-Cell
responsiveness	1932	1946	O
to	1947	1949	O
both	1950	1954	O
VEGF	1955	1959	B-Gene_or_gene_product
and	1960	1963	O
hypoxia	1964	1971	O
.	1971	1972	O

